Cargando…
Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?
Impaired exercise capacity is the key symptom of heart failure (HF) and is associated with reduced quality of life and higher mortality rates. Unfortunately, current therapies, although generally lifesaving, have only small or marginal effects on exercise capacity. Specific strategies to alleviate e...
Autores principales: | Nijholt, Kirsten T., Sánchez‐Aguilera, Pablo I., Voorrips, Suzanne N., de Boer, Rudolf A., Westenbrink, B. Daan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302125/ https://www.ncbi.nlm.nih.gov/pubmed/34957643 http://dx.doi.org/10.1002/ejhf.2407 |
Ejemplares similares
-
Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?
por: Voorrips, Suzanne N., et al.
Publicado: (2022) -
Mitochondrial therapy for doxorubicin cardiomyopathy: nuclear factor-κB to the rescue?
por: Nijholt, Kirsten Theresa, et al.
Publicado: (2020) -
Exercise Training and Heart Failure: A Review of the Literature
por: Morris, Jacqueline H, et al.
Publicado: (2019) -
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
por: Saucedo-Orozco, Huitzilihuitl, et al.
Publicado: (2022) -
Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes
por: Minnock, Dean, et al.
Publicado: (2022)